Increased Risk of Pre-eclampsia After Frozen-Thawed Embryo Transfer in Programming Cycles

Ze Wang, Hong Liu, Haixia Song, Xiufang Li, Jingjing Jiang, Yan Sheng, Yuhua Shi, Ze Wang, Hong Liu, Haixia Song, Xiufang Li, Jingjing Jiang, Yan Sheng, Yuhua Shi

Abstract

Objective: This study aims to investigate whether obstetric complications and perinatal outcomes after frozen embryo transfer (FET) in the programming cycles differ from that in the natural cycles. Methods: We conducted a retrospective cohort study collecting a total of 14,373 singletons born after frozen embryo transfer at the Center for Reproductive Medicine Affiliated to Shandong University from September 2013 to September 2018. The women were divided into two groups according to the regimens for endometrium preparation: either natural cycles (n = 10,211) or programming cycles (n = 4,162). The primary outcomes were the incidence of obstetric complications consisting of pre-eclampsia, gestational diabetes mellitus, placenta previa, placental abruption, and postpartum hemorrhage. The perinatal outcomes included average birthweight, low birthweight (LBW), very LBW, macrosomia, large for gestational age, and small for gestational age. Multivariable logistic regression analysis was performed to adjust for potential confounders. Results: The incidences of pre-eclampsia (8.6 vs. 3.8%) and postpartum hemorrhage (0.7 vs. 0.2%) in the programming FET cycles were significantly higher than those in the natural FET cycles. The logistic regression analysis showed that, compared to the natural FET cycles, the programming FET cycles were associated with an elevated risk of pre-eclampsia (aOR, 2.55; 95% CI, 2.06-3.16) and postpartum hemorrhage (aOR, 2.94; 95% CI, 1.44-5.99). Conclusion: The women with singleton delivery after frozen-thawed embryo transfer in the programming cycles had an elevated risk of pre-eclampsia and postpartum hemorrhage, which was speculated to be associated with the absence of the corpus luteum.

Keywords: corpus luteum; frozen-thawed embryo transfer; hypertensive disorders in pregnancy; pre-eclampsia; programming cycles.

Copyright © 2020 Wang, Liu, Song, Li, Jiang, Sheng and Shi.

References

    1. Roque M, Haahr T, Geber S, Esteves SC, Humaidan P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update. (2019) 25:2–14. 10.1093/humupd/dmy033
    1. Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, et al. . Transfer of fresh versus frozen embryos in ovulatory women. N Engl J Med. (2018) 378:126–36. 10.1056/NEJMoa1705334
    1. Wei D, Liu J-Y, Sun Y, Shi Y, Zhang B, Liu J-Q, et al. . Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial. Lancet. (2019) 393:1310–8. 10.1016/S0140-6736(18)32843-5
    1. Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Hum Reprod. (2012) 27:1343–50. 10.1093/humrep/des036
    1. Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR, et al. . Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. (2015) 30:1724–31. 10.1093/humrep/dev090
    1. Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, Soderstrom-Anttila V, et al. . Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Hum Reprod Update. (2013) 19:87–104. 10.1093/humupd/dms044
    1. Roque M, Bedoschi G, Cecchino GN, Esteves SC. Fresh versus frozen blastocyst transfer. Lancet. (2019) 394:1227–8. 10.1016/S0140-6736(19)31393-5
    1. Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. (2017) 7:CD003414. 10.1002/14651858.CD003414.pub3
    1. von Versen-Höynck F, Narasimhan P, Selamet Tierney ES, Martinez N, Conrad KP, Baker VL, et al. . Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy. Hypertension. (2019) 73:680–90. 10.1161/HYPERTENSIONAHA.118.12046
    1. von Versen-Hoynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis M, et al. . Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. (2019) 73:640–9. 10.1161/HYPERTENSIONAHA.118.12043
    1. Conrad KP. Maternal vasodilation in pregnancy: the emerging role of relaxin. Am J Physiol Regul Integr Comp Physiol. (2011) 301:R267–75. 10.1152/ajpregu.00156.2011
    1. Conrad KP, Baker VL. Corpus luteal contribution to maternal pregnancy physiology and outcomes in assisted reproductive technologies. Am J Physiol Regul Integr Comp Physiol. (2013) 304:R69–72. 10.1152/ajpregu.00239.2012
    1. von Versen-Hoynck F, Strauch NK, Liu J, Chi YY, Keller-Woods M, Conrad KP, et al. . Effect of mode of conception on maternal serum relaxin, creatinine, and sodium concentrations in an infertile population. Reprod Sci. (2019) 26:412–9. 10.1177/1933719118776792
    1. Ginstrom Ernstad E, Wennerholm UB, Khatibi A, Petzold M, Bergh C. Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles. Am J Obstet Gynecol. (2019) 221:126 e121–e118. 10.1016/j.ajog.2019.03.010
    1. Saito K, Kuwahara A, Ishikawa T, Morisaki N, Miyado M, Miyado K, et al. . Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus. Hum Reprod. (2019) 34:1567–75. 10.1093/humrep/dez079
    1. Pare E, Parry S, McElrath TF, Pucci D, Newton A, Lim KH. Clinical risk factors for preeclampsia in the 21st century. Obstet Gynecol. (2014) 124:763–70. 10.1097/AOG.0000000000000451
    1. Bartsch E, Medcalf KE, Park AL, Ray JG, High Risk of Pre-eclampsia Identification Group . Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. (2016) 353:i1753. 10.1136/bmj.i1753

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe